DIAGONAL BIO AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0303 SEK | -2.26% |
|
-1.94% | -91.42% |
| Sales 2021 | 8.67M 820K | Sales 2022 | 3.71M 350K | Capitalization | 10.06M 952K |
|---|---|---|---|---|---|
| Net income 2021 | -11M -1.04M | Net income 2022 | -16M -1.51M | EV / Sales 2021 | 7.06 x |
| Net cash position 2021 | 20.77M 1.96M | Net cash position 2022 | 13.58M 1.28M | EV / Sales 2022 | -0.95 x |
| P/E ratio 2021 |
-5.28
x | P/E ratio 2022 |
-0.65
x | Employees | 4 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 57.22% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.26% | ||
| 1 week | -1.94% | ||
| Current month | -59.65% | ||
| 1 month | -59.38% | ||
| 3 months | -75.76% | ||
| 6 months | -92.42% | ||
| Current year | -91.42% |
1 week
0.03
0.04
1 month
0.030.10
Current year
0.030.61
1 year
0.030.82
3 years
0.0319.87
5 years
0.0319.87
10 years
0.0319.87
| Managers | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 22-12-31 |
| Director of Finance/CFO | 60 | 20-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 22-12-31 |
| Chairman | 68 | 20-12-31 | |
| Director/Board Member | 39 | 20-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-29 | 0.0303 | -2.26% | 988 494 |
| 24-05-28 | 0.031 | -4.32% | 16,856,200 |
| 24-05-27 | 0.0324 | -7.43% | 21,227,300 |
| 24-05-24 | 0.035 | +9.38% | 39,842,320 |
| 24-05-23 | 0.032 | +3.56% | 54,171,080 |
Delayed Quote Nasdaq Stockholm, May 29, 2024 at 03:39 am EDT
More quotes
Diagonal Bio AB is a Sweden-based medical research company. The Company is developing a diagnostic platform (Panviral) for detection of any kind of pathogen. Panviralâs technology is based on rapid isothermal amplification of a pathogenâs genome. Multiple tests can be run in parallel, thereby increasing the sample throughput.
Calendar
2024-05-30
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -91.42% | 1.18M | |
| +54.05% | 58.71B | |
| -2.02% | 41.31B | |
| +37.12% | 39.2B | |
| -10.22% | 27.4B | |
| +13.42% | 26.55B | |
| -21.60% | 18.98B | |
| +2.89% | 12.51B | |
| +22.40% | 11.94B | |
| +27.49% | 12.08B |
- Stock Market
- Equities
- DIABIO Stock
